Obesity and Prostate Cancer: A Role for Adipokines

Slides:



Advertisements
Similar presentations
Volume 60, Issue 4, Pages (October 2011)
Advertisements

Early Detection of Prostate Cancer in 2007
The PSA Era is not Over for Prostate Cancer
Volume 59, Issue 2, Pages (February 2011)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
Volume 70, Issue 1, Pages (July 2016)
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer  Marisa Warmuth,
Renal Cell Carcinoma: Prognostic Factors and Patient Selection
Volume 71, Issue 2, Pages (February 2017)
The Correlation Between Metabolic Syndrome and Prostatic Diseases
Acne: The Role of Medical Nutrition Therapy
Volume 53, Issue 5, Pages (May 2008)
Volume 64, Issue 4, Pages (October 2013)
Volume 69, Issue 1, Pages (January 2016)
Let the Games Begin (with EAU Approval)
Prostate Cancer Epidemic in Sight?
Neeraj Agarwal, Guru Sonpavde, Cora N. Sternberg  European Urology 
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 53, Issue 2, Pages (February 2008)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
The Potential of MicroRNAs as Prostate Cancer Biomarkers
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes  European Urology 
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 70, Issue 1, Pages (July 2016)
Shaheen Alanee, Kasmintan Schrader, Kenneth Offit  European Urology 
Counselling the Prostate Cancer Patient
Prostate Cancer Epidemic in Sight?
James N. Armitage, Stuart O. Irving, Neil A. Burgess  European Urology 
The PSA Era is not Over for Prostate Cancer
Volume 70, Issue 1, Pages e27-e28 (July 2016)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 53, Issue 6, Pages (June 2008)
Leonard S. Marks, Jiaoti Huang  European Urology 
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Tillmann Loch, Pat Fox Fulgham  European Urology 
Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Testicular Cancer Variations in Time and Space in Europe
Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice  Claus Roehrborn  European Urology.
Volume 53, Issue 1, Pages (January 2008)
Neal Shore  European Urology Supplements 
Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi  European Urology 
European Urology is “Your” Journal
Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 
Improving Outcomes in Prostate Cancer: Time to Tackle Bone Disorders
A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study  John Fitzpatrick  European.
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
Economic Burden of Bladder Cancer Across the European Union
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 54, Issue 3, Pages (September 2008)
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Obesity and Prostate Cancer: A Role for Adipokines Tina Mistry, Janet E. Digby, Ken M. Desai, Harpal S. Randeva  European Urology  Volume 52, Issue 1, Pages 46-53 (July 2007) DOI: 10.1016/j.eururo.2007.03.054 Copyright © 2007 European Association of Urology Terms and Conditions

Fig. 1 Diagrammatic representation of some of the possible mechanisms for obesity-related prostate cancer progression. IGF-1=insulin-like growth factor 1; IL-6=interleukin 6; VEGF=vascular endothelial growth factor; SHBG=sex-hormone binding globulin. European Urology 2007 52, 46-53DOI: (10.1016/j.eururo.2007.03.054) Copyright © 2007 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.